Champions Oncology, Inc.
20.10.2021 16:28:12 CEST | ACCESS Newswire | Press release
HACKENSACK, NJ / ACCESSWIRE / October 20, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced the opening of a European laboratory located in the renowned OpenZone Life Sciences Campus in Bresso, Italy, on the doorstep of Milan.
After launching preclinical and clinical GCLP-compliant biomarker services in 2019, Champions Oncology has rapidly grown to be a leader in the industry by providing scientific expertise, unparalleled quality, and innovative data analytics.
OpenZone is a scientific campus conceived by the healthcare company Zambon to create value in the field of Health, by fostering community, competencies, and capital. With the arrival of Champions Oncology, it is home to 34 enterprises and is undergoing a substantial expansion phase. Thanks to a total investment of around 65 million euros, OpenZone will double in size by 2022, growing to cover a surface area of 37,000 square meters with the capacity to host up to 1,200 people.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page."Expanding our laboratory footprint into Europe is a tremendous milestone for Champions," said Ronnie Morris, MD, CEO of Champions Oncology. "Having local/regional access to clinical trial patient samples, some which require less than 24 hours to be processed to achieve accurate readouts, will provide a solution to our clients and also drive growth for our clinical biomarker business in the years to come."
With the unprecedented growth of clinical trials in Europe and the requirement of proximity to access expert biomarker analytical services, Champions is well positioned to serve existing as well as new European clients within the Biotech and Pharmaceutical industries with its expertise in high-dimensional flow cytometry (up to 24-colors) and other analytical techniques as part of Champions' growing portfolio.
About Champions Oncology, Inc.
Champions Oncology is a data-driven research organization, with headquarters in the United States, that leverages an oncology research center of excellence to develop transformative technology and accelerate oncology research and development. This technology ranges from computational-based discovery platforms, unique oncology software solutions, and innovative and proprietary experimental tools such as in vivo, ex-vivo and biomarker platforms. For more information, please visit www.ChampionsOncology.com.
Media Contact:
Rachel Bunting, MS, MBA
Sr. Director, Head of Marketing
Champions Oncology, Inc.
Marketing@championsoncology.com
About OpenZone
OpenZone is the campus, on the doorstep of Milan, dedicated to Health and founded on an approach geared towards open innovation. Conceived by the healthcare company Zambon to build bridges between different languages and worlds, OpenZone mission is to "uniquely create value in Healthcare, by fostering community, competencies and capital". Today the campus is home to 34 enterprises, including some of the foremost biotechnology, pharmaceutical and advanced gene therapy companies, all with a strong penchant for innovation. Work is underway to expand the campus, which, thanks to a total investment of around 65 million euros, will double in size by 2022, growing to cover a surface area of 37,000 square metres, with the capacity to host up to 1,200 people.
OpenZone works closely with all stakeholders in the health sector, to ensure that Milan and Lombardy are increasingly recognized internationally as a territory of excellence for life sciences. Learn more on www.openzone.it/en.
Media Contacts:
Marco Allegrini
Tel: +39 347 339 5615
E: marco.allegrini@zambongroup.com
E: ufficiostampa@openzone.it
Image Building
Cristina Fossati / Angela Fumis
Tel. +39 02 89011300
E: zambon@imagebuilding.it
SOURCE: Champions Oncology, Inc.
View source version on accesswire.com:
https://www.accesswire.com/668789/Champions-Oncology-Expands-Global-Biomarker-Capabilities-with-Opening-of-European-Laboratory-at-OpenZone-Life-Sciences-Campus
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Fermi Outlines Strategic Rationale for Upsized $431 Million Convertible Notes Offering15.7.2026 14:30:00 CEST | Press release
Flexible convertible structure with shareholder-friendly capped call minimizes dilution Proceeds strengthen liquidity in midst of customer and partner negotiations and preserve Fermi's speed-to-power advantage Attractive five-year cost of capital provides run room to advance multiple commercial tracks in parallel DALLAS, TX / ACCESS Newswire / July 15, 2026 / Fermi Inc. (Nasdaq:FRMI)(LSE:FRMI), operating as Fermi America™ ("Fermi" or the "Company"), outlined today the strategic rationale for its recently closed and upsized offering of $431.25 million aggregate principal amount of 5.00% Convertible Senior Notes due 2031 (the "Notes"), which included the exercise in full of the initial purchasers' 13-day option to purchase up to an additional $56.25 million aggregate principal amount of Notes. The Notes are intended to strengthen Fermi's balance sheet, enhance liquidity, and support continued execution of Project Matador as the Company advances tenant, strategic partnership, and power-de
Innodata to Report Second Quarter 2026 Results15.7.2026 14:30:00 CEST | Press release
NEW YORK CITY, NY / ACCESS Newswire / July 15, 2026 / INNODATA INC. (NASDAQ:INOD) today announced that it will report Second Quarter 2026 results after the market closes on Thursday, August 6, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are: (+1) 800 715 9871 North America, Toll Free (+44) 800 358 0970 United Kingdom (+1) 646 307 1963 International Participant Access Code 3150581 For Replay: (+1) 800 770 2030 North America-Toll Free (+44) 203 433 3849 (+1) 609 800 9909 United Kingdom International Playback ID 3150581# Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only
UK Renewable Energy Installer Announces Strategic Partnership to Advance Battery Energy Storage Solutions15.7.2026 13:45:00 CEST | Press release
Excel Energy, a UK renewable energy installer, has announced a strategic partnership with global battery innovator Sigenergy to improve how UK businesses store and use surplus solar energy. LONDON, UK / ACCESS Newswire / July 15, 2026 / The collaboration, which began in April 2026, aims to support the deployment of more efficient energy storage systems that help organisations reduce operational energy costs and progress towards net zero targets. The partnership focuses on enabling businesses to capture excess solar generation and deploy it during peak demand periods, overnight usage, or when grid reliance would otherwise be higher. This approach supports more efficient use of on-site renewable generation and improved overall energy management. By integrating advanced battery storage technology with commercial solar installations, the collaboration is intended to enhance energy resilience for businesses while reducing dependence on grid-supplied electricity. It also supports wider adopt
LiberNovo 2026 Chair Lineup Marks One Month on Sale as Early Bird Savings Enter Final Countdown15.7.2026 10:00:00 CEST | Press release
HONG KONG, HK / ACCESS Newswire / July 15, 2026 / The LiberNovo 2026 lineup, made up of the Omni SE, Omni Pro, and Maxis Series, has reached one month on sale, and its first-release early bird pricing has entered the final stretch. Offers end July 31 at 5:00 p.m. BST in the UK and 6:00 p.m. CEST across the EU. Orders placed before the deadline lock in launch pricing on every model. All three chairs are built on LiberNovo's dynamic support system, which keeps the backrest, neck support, seat, and armrests moving together as you shift, lean, and recline through five stages from 105° to 160°. Three Chairs, One Dynamic Support System The Omni SE keeps things simple. It runs on the same dynamic support, working mechanically with no motor or battery; you set the lumbar depth by hand and the chair does the rest. It ships in Obsidian at the most accessible price in the lineup. The Omni Pro is the premium chair in the lineup. Powered lumbar adjustment and the OmniStretch guided back stretch run
U.S. Polo Assn. Returns to 2026 DMMI Royal Charity Polo Cup as Official Apparel and Team Sponsor14.7.2026 13:00:00 CEST | Press release
Global Brand Supports Prince of Wales' Philanthropic Polo Event, Raising Over £1 Million WEST PALM BEACH, FL AND WINDSOR, UK / ACCESS Newswire / July 14, 2026 / U.S. Polo Assn.®, the global sports brand in partnership with Brand Machine Group (BMG), its licensing partner in the United Kingdom, proudly returned as the Official Apparel and Team Sponsor for the 2026 DMMI Royal Charity Polo Cup. The prestigious charitable event took place on July 10 at the historic Flemish Farm's Guards Polo Club in Windsor Great Park. 1) (left to right) U.S. Polo Assn. Team Accepts 2026 DMMI Royal Charity Polo Cup Trophy: Boo Jalil (BMG), Amr Zeden, Aiyawatt Srivaddhanaprahba, HRH The Princess of Wales, HRH The Prince of Wales, Mark Tomlinson, J. Michael Prince (USPA Global) 2) The 2026 DMMI Royal Charity Polo Cup in full swing at Flemish Farm's Guards Polo Club in Windsor Great Park 3) U.S. Polo Assn. Team Captain, HRH The Prince of Wales, riding a polo pony at the 2026 DMMI Royal Charity Polo Cup Photo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom